Abstract View: 621
PDF Download: 335
Epidemiology and Prevention
Sodium-glucose co-transporter-2 inhibitors in renal failure patients; expanding indications and prospective trends
Hamid Nasri
1 
, Sepideh Ghanbari-nejad
1 , Mina Dehghani
1 , Anastasia Dieti
2* 1 Nickan Research Institute, Isfahan, Iran.
2 Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia 2404, Cyprus.
*Corresponding Author: Corresponding Author: Anastasia Dieti, Email: a.dieti@external.euc.ac.cy, , Email:
anastasiadieti@yahoo.co.uk
Citation: Nasri H, Ghanbari-nejad S, Dehghani M, Dieti A. Sodium-glucose co-transporter-2 inhibitors in renal failure patients; expanding indications and prospective trends. J Ren Endocrinol. 2023;9:e25084. doi: 10.34172/jre.2023.25084.
Abstract View: 622
| years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| 2024 | 20 | 65 | 60 | 65 | 36 | 17 | 18 | 23 | 34 | 22 | 32 | 18 |
| 2023 | | | | 2 | 23 | 44 | 18 | | | 33 | 68 | 24 |
PDF Download: 335
| years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| 2024 | 22 | 19 | 19 | 18 | 42 | 19 | 10 | 12 | 17 | 20 | 15 | 10 |
| 2023 | | | | 3 | 16 | 25 | 21 | | | 13 | 20 | 14 |